Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.52 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.50 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH4 | P08319 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616526 | 1.00 | PAOX (0.57) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| SCHEMBL13616527 | 1.00 | PAOX (0.57) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| SCHEMBL2628445 | 0.91 | PAOX (0.50) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| SCHEMBL19821367 | 0.89 | EPHX2 (0.54) | — | |
| SCHEMBL2628452 | 0.87 | PAOX (0.68) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| Acetone SCHEMBL7080505 | 0.86 | ALDH1A1 (0.68) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| Acetone SCHEMBL7077680 | 0.86 | ALDH1A1 (0.68) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| Acetone SCHEMBL7083131 | 0.86 | ALDH1A1 (0.68) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| Acetone SCHEMBL7079915 | 0.86 | ALDH1A1 (0.68) | PAOXALDH1A1TSHRS1PR2S1PR4 | |
| SCHEMBL19821364 | 0.85 | ALOX5 (0.57) | PAOXALDH1A1TSHRS1PR2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1431280-A1 | ARYL SULFAMATE DERIVATIVES | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | SULT1A1, STS, CYP26A1 | PAOX 2747/4885ALDH1A1 1187/4885TSHR 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.